RxDoctor Payments Data

Helen Chodsky, PA

Surgical · Berkeley, CANPI 1376868497

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 95.8% of the total across 244 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 20.7% — the pattern of someone who eats at a lot of different presentations. Among surgical clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,811in general payments, 2019–2025

Across 244 payments — averaging $32.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Johnson & Johnson$1K
  • Sanofi$1K
  • Incyte Corporation$663
  • Regeneron Healthcare Solutions, Inc.$559
  • Lilly USA, LLC$436
  • plus $2K from 15 others

What the payments were for

  • Food & beverage$7,48796%
  • Education$3254%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,811 in reported general payments places this provider in the 95th percentile of 729 surgical providers in California.

See all surgical providers in California

Medicare billing

Part B allowed, 2024
$262,403
Medicare patients
682
Services billed
9,436

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab44$159,625
Clobetasol Propionate42$2,291
Fluocinonide63$1,889
Tacrolimus16$1,521
Metronidazole41$1,386
Ketoconazole77$1,375
Fluorouracil19$1,357
Econazole Nitrate31$1,119
Clindamycin Phosphate27$903
Triamcinolone Acetonide124$868
Azelaic Acid11$663
Nystatin31$428
Imiquimod12$403
Mupirocin34$347
Doxycycline Hyclate25$315

Paid to pharmacies, not to this prescriber.

Other surgical in Berkeley

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →